NORD comparison of two versions of the Right to Try Act
Published: May 21, 2018
Tagged in: Access to Innovative Medicines and Therapies, Right to Try
For decades, NORD has pursued federal and state policies that will change the lives of Americans impacted by rare diseases for the better. NORD’s work can be viewed below. This page is updated daily to provide timely information. Please contact us if you have questions or need additional information.
NORD comparison of two versions of the Right to Try Act
Published: May 21, 2018
Tagged in: Access to Innovative Medicines and Therapies, Right to Try
Coalition letter in opposition to the Right to Try Act (S.204)
Published: May 21, 2018
Tagged in: Access to Innovative Medicines and Therapies, Right to Try
Sign-on letter to the Senate from 106 patient and provider organizations in opposition to the Right to Try Act
Published: Mar 22, 2018
Tagged in: Access to Innovative Medicines and Therapies, Right to Try
Updated NORD one-pager detailing our opposition to the Right to Try Act
Published: Mar 19, 2018
Tagged in: Access to Innovative Medicines and Therapies, Right to Try
Updated sign-on letter from over 100 patient and provider organizations in opposition to the Right to Try Act
Published: Mar 19, 2018
Tagged in: Access to Innovative Medicines and Therapies, Right to Try
Sign-on letter from 82 patient organizations in opposition to the newest version of the Right to Try Act
Published: Mar 12, 2018
Tagged in: Access to Innovative Medicines and Therapies, Right to Try